Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

Risks of Not Training Personnel Before SOP Implementation

Posted on By

Risks of Not Training Personnel Before SOP Implementation GMP Risk: Failure to Train Personnel Prior to SOP Implementation Introduction to the Audit Finding 1. Nature of the Finding This finding involves SOPs becoming effective and being used in GMP operations before employees are trained on their content. 2. Why It’s a Compliance Breach GMP guidelines…

Read More “Risks of Not Training Personnel Before SOP Implementation” »

GMP Audit Findings, Training Failure

Why Assessing SOP Training Effectiveness Is Crucial in GMP Compliance

Posted on By

Why Assessing SOP Training Effectiveness Is Crucial in GMP Compliance GMP Compliance Gap: Absence of Post-Training Assessment on SOPs Introduction to the Audit Finding 1. Audit Gap Definition This issue arises when personnel are marked “trained” on SOPs without any evaluation to confirm understanding and readiness. 2. GMP Expectation Regulators expect that training should not…

Read More “Why Assessing SOP Training Effectiveness Is Crucial in GMP Compliance” »

GMP Audit Findings, Training Failure

GMP Non-Compliance: SOPs Missing Audit Trail Expectations

Posted on By

GMP Non-Compliance: SOPs Missing Audit Trail Expectations Data Integrity Violation: Missing Audit Trail Expectations in SOPs Introduction to the Audit Finding 1. Audit Finding Overview This compliance gap involves SOPs that do not include expectations for audit trail generation, review, or retention, particularly in computerized systems. 2. Relevance to Data Integrity An audit trail is…

Read More “GMP Non-Compliance: SOPs Missing Audit Trail Expectations” »

Data Integrity Gaps, GMP Audit Findings

GMP Violation: Absence of SOPs for Electronic Record Handling

Posted on By

GMP Violation: Absence of SOPs for Electronic Record Handling GMP Non-Compliance Due to Missing SOPs for Electronic Record Handling Introduction to the Audit Finding 1. Summary of Finding Electronic records critical to GMP operations are managed without documented procedures—violating data integrity expectations. 2. Data Governance Concern Without a defined SOP, electronic data becomes vulnerable to…

Read More “GMP Violation: Absence of SOPs for Electronic Record Handling” »

Data Integrity Gaps, GMP Audit Findings

GMP Non-Compliance: Practice Deviating from SOP Procedures

Posted on By

GMP Non-Compliance: Practice Deviating from SOP Procedures When Actual Practices Don’t Match SOPs: A Critical GMP Compliance Risk Introduction to the Audit Finding 1. Nature of the Finding This issue arises when operations are not performed as described in approved Standard Operating Procedures (SOPs). 2. Compliance Risk Such discrepancies are viewed as serious breaches of…

Read More “GMP Non-Compliance: Practice Deviating from SOP Procedures” »

GMP Audit Findings, Mismatch Between SOPs and Practice

GMP Gap: Aseptic Processing Steps Not Clearly Defined

Posted on By

GMP Gap: Aseptic Processing Steps Not Clearly Defined Undefined Aseptic Processing Steps: A Compliance Risk in Sterile Manufacturing Introduction to the Audit Finding 1. What Was Observed? SOPs for aseptic manufacturing lacked detailed steps for critical operations such as gowning, line clearance, and interventions. 2. Why It’s a Serious Concern Incomplete aseptic procedures create opportunities…

Read More “GMP Gap: Aseptic Processing Steps Not Clearly Defined” »

Critical Operations, GMP Audit Findings

GMP Non-Compliance: SOPs Not Updated for Revised Annex 1

Posted on By

GMP Non-Compliance: SOPs Not Updated for Revised Annex 1 Annex 1 Compliance Gaps: Outdated SOPs in Sterile Pharmaceutical Operations Introduction to the Audit Finding 1. Nature of the Gap Standard Operating Procedures (SOPs) in sterile manufacturing were not revised to reflect the latest EU GMP Annex 1 (2022) updates. 2. Significance of Annex 1 (2022)…

Read More “GMP Non-Compliance: SOPs Not Updated for Revised Annex 1” »

GMP Audit Findings, Regulatory Change

GMP Gap: Temporary SOP Changes Not Documented

Posted on By

GMP Gap: Temporary SOP Changes Not Documented Failure to Document Temporary SOP Changes: A Critical GMP Compliance Breakdown Introduction to the Audit Finding 1. Nature of the Finding Temporary changes made to standard procedures were executed during manufacturing or quality operations but not documented formally through the change control system. 2. Why It’s a Compliance…

Read More “GMP Gap: Temporary SOP Changes Not Documented” »

Emergency Changes, GMP Audit Findings

Audit Risk: Absence of SOPs for Contract Manufacturing Oversight

Posted on By

Audit Risk: Absence of SOPs for Contract Manufacturing Oversight Contract Manufacturing Oversight Lapses: The Risk of Missing Oversight SOPs Introduction to the Audit Finding 1. Audit Observation Overview Pharmaceutical firms outsourcing operations to Contract Manufacturing Organizations (CMOs) often fail to maintain internal SOPs for oversight and governance. 2. GMP Oversight Is Mandatory Even when operations…

Read More “Audit Risk: Absence of SOPs for Contract Manufacturing Oversight” »

GMP Audit Findings, Third-Party SOPs

GMP Failure: No SOP for Regulatory Audit Preparation

Posted on By

GMP Failure: No SOP for Regulatory Audit Preparation Absence of Audit Preparation SOP: A Critical Inspection Readiness Gap Introduction to the Audit Finding 1. Audit Readiness Expectation Regulatory authorities expect pharmaceutical companies to have defined SOPs outlining how they prepare for GMP inspections. 2. The Finding Explained Absence of a formal SOP for audit readiness…

Read More “GMP Failure: No SOP for Regulatory Audit Preparation” »

GMP Audit Findings, Inspection Readiness

Posts pagination

Previous 1 2 3 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme